focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMan Regulatory News (EMG)

Share Price Information for Man (EMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 266.60
Bid: 275.00
Ask: 244.20
Change: 7.00 (2.70%)
Spread: -30.80 (-11.20%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 259.60
EMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

28 Apr 2022 17:40

RNS Number : 7741J
Man Group plc
28 April 2022
 

Transactions in own shares

 

Man Group plc (the "Company") announces that it has purchased the following number of its ordinary shares of 3 3/7 US cents on the London Stock Exchange through J.P. Morgan Securities plc as part of the share buyback programme announced on 8 December 2021.

 

Date of purchase:

28 April 2022

 

Number of ordinary shares purchased:

945,000

 

Time of transaction:

08:00 to 16:30

 

Highest price per share:

235.4000

 

Lowest price per share:

232.1000

 

Weighted average price per share:

233.6177

 

The Company intends to hold the purchased shares in treasury. Following the purchase and settlement of these shares, the Company will hold 101,916,584 of its ordinary shares in treasury and will have 1,341,729,073 ordinary shares in issue (excluding treasury shares).

 

Since the commencement of the share repurchase programme, the Company has repurchased 67,556,158 ordinary shares in aggregate at a weighted average price of 210.8879 pence per share.

 

All transactions under this programme will be published on the Company's website (www.man.com) on a weekly basis.

 

Enquiries

Karan Shirgaokar

Director, Investor Relations

+44 (0)20 7144 1434

investor.relations@man.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSPPUBPCUPPGQR
Date   Source Headline
19th Aug 202112:27 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
19th Aug 202112:23 pmGNWMan Group PLC : Form 8.3 - Vectura Group plc
19th Aug 20219:00 amRNSInterim Dividend Conversion Rate
18th Aug 20215:25 pmRNSTransaction in Own Shares
18th Aug 20218:24 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
17th Aug 20216:03 pmRNSTransaction in Own Shares
17th Aug 202110:24 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
16th Aug 20215:59 pmRNSTransaction in Own Shares
16th Aug 202112:05 pmGNWMan Group PLC : Form 8.3 - Strongbridge biopharma plc
13th Aug 20215:20 pmRNSTransaction in Own Shares
13th Aug 202111:05 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
12th Aug 20215:57 pmRNSTransaction in Own Shares
12th Aug 202111:23 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
11th Aug 20215:45 pmRNSTransaction in Own Shares
11th Aug 202110:36 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
11th Aug 20217:00 amRNSTransaction in Own Shares
10th Aug 202111:59 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
10th Aug 20217:00 amRNSShare buyback programme of up to $100 million
9th Aug 20219:41 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
9th Aug 20219:39 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
6th Aug 20219:59 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
5th Aug 202110:30 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
5th Aug 202110:26 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
4th Aug 20212:12 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
4th Aug 20212:09 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
3rd Aug 202112:28 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
3rd Aug 202112:25 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
2nd Aug 20211:42 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
2nd Aug 20211:38 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
2nd Aug 20211:34 pmGNWMan Group PLC : Form 8.3 - John Laing Group plc
2nd Aug 20217:00 amRNSTotal Voting Rights
30th Jul 20211:27 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
30th Jul 20211:25 pmGNWMan Group PLC : Form 8.3 - St.Modwen Properties plc
30th Jul 20211:20 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
29th Jul 20214:20 pmRNSDirector/PDMR Shareholding
29th Jul 20211:56 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
29th Jul 20211:54 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
29th Jul 20211:51 pmGNWMan Group PLC : Form 8.3 - Morrison (WM) Supermarket plc
28th Jul 20216:01 pmRNSTransaction in Own Shares
28th Jul 20211:40 pmGNWMan Group PLC : Form 8.3 - Strongbridge biopharma plc
28th Jul 20211:32 pmGNWMan Group PLC : Form 8.3 - Morrison (WM) Supermarket plc
28th Jul 20217:00 amRNSHalf-year Report
27th Jul 20215:45 pmRNSTransaction in Own Shares
27th Jul 202110:46 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
27th Jul 202110:40 amGNWMan Group PLC : Form 8.3 - Morrison (WM) Supermarket plc
26th Jul 20215:50 pmRNSTransaction in Own Shares
26th Jul 20212:21 pmGNWMan Group PLC : Form 8.3 - Morrison (WM) Supermarket plc
26th Jul 20212:17 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
23rd Jul 20215:57 pmRNSTransaction in Own Shares
23rd Jul 202111:55 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.